There were three companies in cities associated with Bergen County that received FDA citations as a result of three inspections conducted in the county in December 2024, according to reports from the U.S. Food and Drug Administration (FDA).
This is unchanged from the number of companies cited in the previous month.
The citations in the county include:
- The responsibilities and procedures applicable to the quality control unit are not.
- Buildings used in the manufacture, processing, packing, or holding of a drug product do not have the suitable construction and location to facilitate cleaning, maintenance, and proper operations.
- Equipment used in the manufacture, processing, packing or holding of drug products is not of appropriate design to facilitate operations for its.
Most of the companies cited were involved in the Drugs sector.
Of the companies cited, two should take voluntary actions to correct their managing operations (66.7%). Additionally, one company had to take regulatory and/or administrative actions (33.3%).
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Company Name | Area of Business | Inspection Date | Issue Cited |
|---|---|---|---|
| Cosmetic Essence, Inc. | Drugs | 12/06/2024 | Cleaning / Sanitizing / Maintenance |
| Cosmetic Essence, Inc. | Drugs | 12/06/2024 | Investigations of discrepancies, failures |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Procedures not in writing, fully followed |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Buildings of Suitable Size, Construction, Location |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Equipment Design, Size and Location |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Absence of Written Procedures |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Scientifically sound laboratory controls |
| Jamol Laboratories, Inc. | Drugs | 12/12/2024 | Investigations of discrepancies, failures |
| Specialty Vision, LLC | Devices | 12/19/2024 | Quality System Procedures |
| Specialty Vision, LLC | Devices | 12/19/2024 | Documentation |
| Specialty Vision, LLC | Devices | 12/19/2024 | Product rework procedures, Lack of or inadequate procedures |


